MIRA INFORM REPORT

 

 

Report Date :

6th June 2006

 

IDENTIFICATION DETAILS

 

Name :

ASSIA CHEMICAL INDUSTRIES LTD

 

 

Registered Office :

2, Denmark Street, Petach Tikva – 49517, Israel

 

 

Country :

Israel

 

 

Date of Incorporation :

1957

 

 

Com. Reg. No.:

51-016828-9

 

 

Legal Form :

Private Limited Liabilities Company

 

 

Line of Business :

Manufacturers, Distributors & Exporters of Fine Chemicals for the Pharmaceutical Industry.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 1,200,000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


NAME

 

ASSIA CHEMICAL INDUSTRIES LTD.

 

 

ADDRESS

 

2, DENMARK STREET,

PETACH TIKVA-49517, ISRAEL.

 

P.O.BOX 3190,

PETACH TIKVA-49127.

 

TELEPHONE : 03-9267338

FAX                    : 03-9267477

 

 

CAPTION ADDRESS SERVES AS SUBJECT'S REGISTERED ADDRESS.

 

INTERNET SITE: www.tevapharm.com (OF GROUP)

 

 

SUMMARY

 

YEAR STARTED

1957

 

 

CORPORATE FORM

PRIVATE LIMITED LIABILITIES COMPANY

 

 

TOTAL STAFF

180

 

 

SALES TURNOVER

US$ 30,000,000.

 

 

FINANCIAL CONDITION

GOOD

 

 

OPERATING TREND

STEADY

 

 

BUSINESS RELATIONS

REGARDED AS GOOD FOR THEIR COMMITMENTS

 

 

PAYMENT

REGULAR

 

 

 

COURT SENTENCE AGAINST GROUP'S C.E.O. OVERRULED FOLLOWING AN APPEAL.

 

 

CREDIT RISK

LOW

 

 

CREDIT LIMIT

OUR RECORDS DISCLOSE A MAXIMUM CREDIT AMOUNT OF US$ 1,200,000.

 

 

LEGAL STATUS

 

PRIVATE LIMITED COMPANY INCORPORATED PER FILE NO. 51-016828-9 ON 14.08.1957.

 

 

SHAREHOLDERS

 

 "TEVA PHARMACEUTICAL INDUSTRIES LTD." - (15,999,999 ORDINARY SHARES)

 

"SALOMON LEVIN & ELSTEIN LTD." - (1 ORDINARY SHARE)

 

THE PARENT COMPANY, "TEVA PHARMACEUTICAL INDUSTRIES LTD.", IS A PUBLIC LIMITED COMPANY, SHARES TRADED ON THE TEL AVIV AND NEW YORK STOCK EXCHANGES. 

 

THE MINOR SHAREHOLDER, "SALOMON LEVIN & ELSTEIN LTD.", IS A SUBSIDIARY OF "TEVA PHARMACEUTICAL INDUSTRIES LTD.".

 

 

DIRECTORS

 

DAN SHMUEL ZISKIEND - CHAIRMAN, APPOINTED ON 13.11.1979

 

HAIM BENYAMINI, APPOINTED ON 15.02.1990

 

MERON MAN, APPOINTED ON 01.10.1990

 

 

MANAGEMENT

 

C.E.O:                                                   ISRAEL MAKOV

 

C.F.O.:                                                  DAN SHMUEL ZISKIEND, BORN 1944

 

H.R. MANAGER:                                    HAIM BENYAMINI, BORN 1938

 

 

HISTORY

 

SUBJECT WAS REGISTERED UNDER THE TITLE "CHEMICALS EXPORT INDUSTRIES OF ASSA LTD." AND ON 06.02.1977 CHANGED TO PRESENT TITLE.

 

 

 

BUSINESS ACTIVITIES

 

PHARMACEUTICALS

 

S.I.C.: 28.34.0000

          28.33.0110

 

MANUFACTURERS, DISTRIBUTORS & EXPORTERS OF FINE CHEMICALS FOR THE PHARMACEUTICAL INDUSTRY.

 

 

PREMISES

 

PRODUCTION AND BUSINESS ARE CONDUCTED FROM OFFICES AND PLANT PREMISES SITUATED AT CAPTION ADDRESS.

 

REPORTEDLY ("GLOBES", 03.01.2000), THE "TEVA" GROUP FROZE A PLANT TO ERECT 50,000 SQ. METER OFFICES AND LABORATORIES PREMISES TOGETHER WITH 190 RESIDENTIAL APARTMENTS ON ITS 5 ACRE PLOT AT CAPTION ADDRESS. THE "TEVA" GROUP IS NEGOTIATING ERECTING ITS HEAD OFFICES AT THE "ABIC" PREMISES IN SOUTH NETANYA AND IS CONTEMPLATING TRANSFERRING SUBJECT'S PLANT TO TO RAMAT HOVAV IN THE NEGEV REGION. 

 

 

STAFF

 

180 EMPLOYEES

 

 

SHARE CAPITAL

 

AUTHORISED: NIS 50,000,000.00

 

COMPRISING: 50,000,000 ORDINARY SHARES @ NIS 1.00 EACH

 

ISSUED:     16,000,000 SHARES (NIS 16,000,000.-)

 

SHARE CAPITAL INCREASED BY IL (ISRAELI LIRA, AN OLD CURRENCY IN FORCE AT THAT TIME) 30,000,000 ON 11.03.1978, BY (OLD) IS 2,500,000 ON 10.09.1981, BY (OLD) IS 7,500,000 ON 30.05.1983, BY NIS 1,985,000 ON 24.12.1991 AND BY NIS 48,000,000 ON 03.07.1995.

 

 

PUBLIC RECORD INFORMATION

 

20 CHARGES WERE FORMERLY REGISTERED AGAINST SUBJECT'S ASSETS AS COLLATERAL FOR LOANS FROM 25.07.1971 TO 24.05.1981 AND SUBSEQUENTLY REMOVED UNTIL 15.12.1990.

 

NO CURRENT RECORD OF PLEDGED ASSETS.

 

 

FINANCIAL INFORMATION

 

SUBJECT AS A PRIVATE COMPANY DOES NOT PUBLISH BALANCE SHEET OR RELATED INFORMATION.

 

THE PARENT COMPANY DOES NOT DISCLOSE FINANCIAL INFORMATION REGARDING SUBSIDIARIES INCLUDED IN ITS CONSOLIDATED BALANCE SHEET.

 

ANNUAL TURNOVER ESTIMATED AT US$ 30,000,000.

 

ANNUAL CONSOLIDATED 2004 TURNOVER OF "TEVA PHARMACEUTICAL INDUSTRIES LTD." AMOUNTED TO US$ 5,058,808,000.

 

 

RECORDS

 

NOTHING DETRIMENTAL UNCOVERED.

 

FOR THE RECORD: MR. ELI HOROWITZ, C.E.O. OF THE "TEVA" GROUP, WAS CHARGED IN JUNE 1994 OF FICTITIOUSLY REPORTING OF HIGHER IMPORT EXPENSES RELATED TO "PROMEDICO LTD.". "MR. BENJAMIN YESSELSON WAS ALSO CHARGED IN THIS CASE. MR. BENJAMIN YESSELSON AND  MR. ELI HOROWITZ WERE SENTENCED ON 14.01.1999 TO 18 MONTHS SUSPENDED IMPRISONMENT AND A FINE OF NIS 700,000 (THEN US$ 170,000) EACH. FOLLOWING AN APPEAL TO THE SUPREME COURT MR. BENJAMIN YESSELSON AND MR. ELI HOROWITZ WERE FOUND NOT-GUILTY AND THE SENTENCES WERE OVERRULED.

 

 

BANKERS

 

BANK HAPOALIM LTD., 1 DENMARK STREET, PETACH TIKVA (12-552)

 

BANK LEUMI LEISRAEL LTD., 19 HERZL STREET, TEL AVIV (10-800)

 

ISRAEL DISCOUNT BANK LTD., 27-31 YEHUDA HALEVI STREET, TEL AVIV (11-010)


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions